CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 600,000 shares at $162,660.00 ($97,596,000,000)
- 4 Open-market buy 10% owner bought 600,000 shares at $162,660.00 ($97,596,000,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 2,500,000 shares
- 4 Shares withheld for taxes Director gave up 356,400 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 2,940,956 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 6,314,219 shares (to pay taxes)
- 4 Option exercise Director acquired 600,000 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 297,000 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise 10% owner acquired 9,610,902 shares (option exercise)
- 4 Option exercise 10% owner acquired 38,833,000 shares (option exercise)
Page 4 of 11 · 219 filings